Cullin-3 regulates vascular smooth muscle function and arterial blood pressure via PPARγ and RhoA/Rho-kinase

Cell Metabolism

Volumn 16, Issue 4, 2012, Pages 462-472

  Pelham, Christopher J ^a   Ketsawatsomkron, Pimonrat ^a   Groh, Séverine ^a   Grobe, Justin L ^a   De Lange, Willem J ^a   Ibeawuchi, Stella Rita C ^a   Keen, Henry L ^a   Weatherford, Eric T ^a   Faraci, Frank M ^a   Sigmund, Curt D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CULLIN; CULLIN 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; IN VIVO STUDY; MOUSE; MUSCLE FUNCTION; NEDDYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER; VASCULAR RING; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOOD PRESSURE; CULLIN PROTEINS; HEK293 CELLS; HUMANS; MICE; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; PPAR GAMMA; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

MUS; MUS MUSCULUS;

EID: 84867084491     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2012.08.011     Document Type: Article

References (45)

1. I. Barroso, M. Gurnell, V.E. Crowley, M. Agostini, J.W. Schwabe, M.A. Soos, G.L. Maslen, T.D. Williams, H. Lewis, and A.J. Schafer Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension Nature 402 1999 880 883
2. L.B. Beder, M. Gunduz, M. Ouchida, E. Gunduz, A. Sakai, K. Fukushima, H. Nagatsuka, S. Ito, N. Honjo, K. Nishizaki, and K. Shimizu Identification of a candidate tumor suppressor gene RHOBTB1 located at a novel allelic loss region 10q21 in head and neck cancer J. Cancer Res. Clin. Oncol. 132 2006 19 27
3. J. Berthold, K. Schenková, S. Ramos, Y. Miura, M. Furukawa, P. Aspenström, and F. Rivero Characterization of RhoBTB-dependent Cul3 ubiquitin ligase complexes - evidence for an autoregulatory mechanism Exp. Cell Res. 314 2008 3453 3465
4. A.M. Beyer, W.J. de Lange, C.M. Halabi, M.L. Modrick, H.L. Keen, F.M. Faraci, and C.D. Sigmund Endothelium-specific interference with peroxisome proliferator activated receptor gamma causes cerebral vascular dysfunction in response to a high-fat diet Circ. Res. 103 2008 654 661
5. L.M. Boyden, M. Choi, K.A. Choate, C.J. Nelson-Williams, A. Farhi, H.R. Toka, I.R. Tikhonova, R. Bjornson, S.M. Mane, and G. Colussi Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities Nature 482 2012 98 102
6. K. Budzyn, P.D. Marley, and C.G. Sobey Targeting Rho and Rho-kinase in the treatment of cardiovascular disease Trends Pharmacol. Sci. 27 2006 97 104
7. L. Chang, L. Villacorta, J. Zhang, M.T. Garcia-Barrio, K. Yang, M. Hamblin, S.E. Whitesall, L.G. D'Alecy, and Y.E. Chen Vascular smooth muscle cell-selective peroxisome proliferator-activated receptor-gamma deletion leads to hypotension Circulation 119 2009 2161 2169
8. Y. Chen, Z. Yang, M. Meng, Y. Zhao, N. Dong, H. Yan, L. Liu, M. Ding, H.B. Peng, and F. Shao Cullin mediates degradation of RhoA through evolutionarily conserved BTB adaptors to control actin cytoskeleton structure and cell movement Mol. Cell 35 2009 841 855
9. E.H. Chew, T. Poobalasingam, C.J. Hawkey, and T. Hagen Characterization of cullin-based E3 ubiquitin ligases in intact mammalian cells - evidence for cullin dimerization Cell. Signal. 19 2007 1071 1080
10. K. Chitaley, and R.C. Webb Nitric oxide induces dilation of rat aorta via inhibition of rho-kinase signaling Hypertension 39 2002 438 442
11. J.H. Choi, A.S. Banks, T.M. Kamenecka, S.A. Busby, M.J. Chalmers, N. Kumar, D.S. Kuruvilla, Y. Shin, Y. He, and J.B. Bruning Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation Nature 477 2011 477 481
12. Q.N. Diep, M. El Mabrouk, J.S. Cohn, D. Endemann, F. Amiri, A. Virdis, M.F. Neves, and E.L. Schiffrin Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma Circulation 105 2002 2296 2302
13. J. Dill, A.R. Patel, X.L. Yang, R. Bachoo, C.M. Powell, and S. Li A molecular mechanism for ibuprofen-mediated RhoA inhibition in neurons J. Neurosci. 30 2010 963 972
14. D.J. Graham, R. Ouellet-Hellstrom, T.E. MaCurdy, F. Ali, C. Sholley, C. Worrall, and J.A. Kelman Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone JAMA 304 2010 411 418
15. H. Gronemeyer, J.A. Gustafsson, and V. Laudet Principles for modulation of the nuclear receptor superfamily Nat. Rev. Drug Discov. 3 2004 950 964
16. C.M. Halabi, A.M. Beyer, W.J. de Lange, H.L. Keen, G.L. Baumbach, F.M. Faraci, and C.D. Sigmund Interference with PPAR gamma function in smooth muscle causes vascular dysfunction and hypertension Cell Metab. 7 2008 215 226
17. C.M. Halabi, and C.D. Sigmund Peroxisome proliferator-activated receptor-gamma and its agonists in hypertension and atherosclerosis: mechanisms and clinical implications Am. J. Cardiovasc. Drugs 5 2005 389 398
18. L. Jin, Z. Ying, R.H. Hilgers, J. Yin, X. Zhao, J.D. Imig, and R.C. Webb Increased RhoA/Rho-kinase signaling mediates spontaneous tone in aorta from angiotensin II-induced hypertensive rats J. Pharmacol. Exp. Ther. 318 2006 288 295
19. H.L. Keen, C.M. Halabi, A.M. Beyer, W.J. de Lange, X. Liu, N. Maeda, F.M. Faraci, T.L. Casavant, and C.D. Sigmund Bioinformatic analysis of gene sets regulated by ligand-activated and dominant-negative peroxisome proliferator-activated receptor gamma in mouse aorta Arterioscler. Thromb. Vasc. Biol. 30 2010 518 525
20. H.L. Keen, M.J. Ryan, A. Beyer, S. Mathur, T.E. Scheetz, B.D. Gackle, F.M. Faraci, T.L. Casavant, and C.D. Sigmund Gene expression profiling of potential PPARgamma target genes in mouse aorta Physiol. Genomics 18 2004 33 42
21. P. Ketsawatsomkron, C.J. Pelham, S. Groh, H.L. Keen, F.M. Faraci, and C.D. Sigmund Does peroxisome proliferator-activated receptor-gamma (PPAR gamma) protect from hypertension directly through effects in the vasculature? J. Biol. Chem. 285 2010 9311 9316
22. N. Kobayashi, T. Ohno, K. Yoshida, H. Fukushima, Y. Mamada, M. Nomura, H. Hirata, Y. Machida, M. Shinoda, N. Suzuki, and H. Matsuoka Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats Am. J. Hypertens. 21 2008 576 581
23. U. Kossatz, K. Breuhahn, B. Wolf, M. Hardtke-Wolenski, L. Wilkens, D. Steinemann, S. Singer, F. Brass, S. Kubicka, and B. Schlegelberger The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells from becoming tumor-initiating cells J. Clin. Invest. 120 2010 3820 3833
24. Y.C. Leck, Y.Y. Choo, C.Y. Tan, P.G. Smith, and T. Hagen Biochemical and cellular effects of inhibiting Nedd8 conjugation Biochem. Biophys. Res. Commun. 398 2010 588 593
25. J.D. Lewis, A. Ferrara, T. Peng, M. Hedderson, W.B. Bilker, C.P. Quesenberry Jr., D.J. Vaughn, L. Nessel, J. Selby, and B.L. Strom Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study Diabetes Care 34 2011 916 922
26. G. Li, and T. Leff Altered promoter recycling rates contribute to dominant-negative activity of human peroxisome proliferator-activated receptor-gamma mutations associated with diabetes Mol. Endocrinol. 21 2007 857 864
27. H. Louis-Dit-Picard, J. Barc, D. Trujillano, S. Miserey-Lenkei, N. Bouatia-Naji, O. Pylypenko, G. Beaurain, A. Bonnefond, O. Sand, C. Simian International Consortium for Blood Pressure (ICBP) KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron Nat. Genet. 44 2012 456 460 S1-S3
28. J.J. Maguire, and A.P. Davenport Regulation of vascular reactivity by established and emerging GPCRs Trends Pharmacol. Sci. 26 2005 448 454
29. K. Momotani, M.V. Artamonov, D. Utepbergenov, U. Derewenda, Z.S. Derewenda, and A.V. Somlyo p63RhoGEF couples Gα(q/11)-mediated signaling to Ca2+ sensitization of vascular smooth muscle contractility Circ. Res. 109 2011 993 1002
30. M. Nethe, and P.L. Hordijk The role of ubiquitylation and degradation in RhoGTPase signalling J. Cell Sci. 123 2010 4011 4018
31. M.D. Petroski, and R.J. Deshaies Function and regulation of cullin-RING ubiquitin ligases Nat. Rev. Mol. Cell Biol. 6 2005 9 20
32. S.H. Ramirez, D. Heilman, B. Morsey, R. Potula, J. Haorah, and Y. Persidsky Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses Rho GTPases in human brain microvascular endothelial cells and inhibits adhesion and transendothelial migration of HIV-1 infected monocytes J. Immunol. 180 2008 1854 1865
33. S. Sakurada, H. Okamoto, N. Takuwa, N. Sugimoto, and Y. Takuwa Rho activation in excitatory agonist-stimulated vascular smooth muscle Am. J. Physiol. Cell Physiol. 281 2001 C571 C578
34. S. Sakurada, N. Takuwa, N. Sugimoto, Y. Wang, M. Seto, Y. Sasaki, and Y. Takuwa Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction Circ. Res. 93 2003 548 556
35. V. Sauzeau, H. Le Jeune, C. Cario-Toumaniantz, A. Smolenski, S.M. Lohmann, J. Bertoglio, P. Chardin, P. Pacaud, and G. Loirand Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle J. Biol. Chem. 275 2000 21722 21729
36. D.B. Savage, G.D. Tan, C.L. Acerini, S.A. Jebb, M. Agostini, M. Gurnell, R.L. Williams, A.M. Umpleby, E.L. Thomas, and J.D. Bell Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma Diabetes 52 2003 910 917
37. K. Schenkova, J. Lutz, M. Kopp, S. Ramos, and F. Rivero MUF1/Leucine-Rich Repeat Containing 41 (LRRC41), a Substrate of RhoBTB-Dependent Cullin 3 Ubiquitin Ligase Complexes, Is a Predominantly Nuclear Dimeric Protein J. Mol. Biol. 422 2012 659 673
38. C.D. Sigmund Endothelial and vascular muscle PPARgamma in arterial pressure regulation: lessons from genetic interference and deficiency Hypertension 55 2010 437 444
39. M.A. Smith, J.M. Maris, R. Gorlick, E.A. Kolb, R. Lock, H. Carol, S.T. Keir, C.P. Reynolds, M.H. Kang, and C.L. Morton Initial testing of the investigational NEDD8-activating enzyme inhibitor MLN4924 by the pediatric preclinical testing program Pediatr. Blood Cancer 59 2012 246 253
40. T.A. Soucy, P.G. Smith, M.A. Milhollen, A.J. Berger, J.M. Gavin, S. Adhikari, J.E. Brownell, K.E. Burke, D.P. Cardin, and S. Critchley An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer Nature 458 2009 732 736
41. Y. Toriumi, M. Hiraoka, M. Watanabe, and M. Yoshida Pioglitazone reduces monocyte adhesion to vascular endothelium under flow by modulating RhoA GTPase and focal adhesion kinase FEBS Lett. 553 2003 419 422
42. Y.S. Tsai, H.J. Kim, N. Takahashi, H.S. Kim, J.R. Hagaman, J.K. Kim, and N. Maeda Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma J. Clin. Invest. 114 2004 240 249
43. S. Wakino, K. Hayashi, T. Kanda, S. Tatematsu, K. Homma, K. Yoshioka, I. Takamatsu, and T. Saruta Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2 Circ. Res. 95 2004 e45 e55
44. A. Wirth, Z. Benyó, M. Lukasova, B. Leutgeb, N. Wettschureck, S. Gorbey, P. Orsy, B. Horváth, C. Maser-Gluth, and E. Greiner G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension Nat. Med. 14 2008 64 68
45. J.T. Wu, H.C. Lin, Y.C. Hu, and C.T. Chien Neddylation and deneddylation regulate Cul1 and Cul3 protein accumulation Nat. Cell Biol. 7 2005 1014 1020